Evidence map›Paper›PMID 25486437›Full record

ArticleAnalytical chemistry2015

Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction.

Yu Huang, Yang Mao, Chengli Zong, Cheng Lin, Geert-Jan Boons, Joseph Zaia

Abstract read
In one paragraph

Article in Analytical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Synthetic biology for heparin biomanufacturing.Bioresources and bioprocessing · 2026
    Review
  2. Article
  3. Article
  4. Untangling Heparan Sulfate 3-Analytical chemistry · 2025
    Article
  5. Increased 3-Science advances · 2023
    Article
  6. Article
  7. Article
  8. Emerging chemical and biochemical tools for studying 3-American journal of physiology. Cell physiology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Synthesis of 3-Biochemistry · 2020
    Article
  13. Review
  14. ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu HuangDepartment of Biochemistry, Boston University Medical Campus , 670 Albany Street, Boston, Massachusetts 02118, United States.
Yang Mao
Chengli Zong
Cheng Lin
Geert-Jan Boons
Joseph Zaia

Funding

TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Mass Spectrometry Resource for Biology and MedicineP41GM104603 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2017
$10.4M
Post-biosynthetic Remodeling of Heparan SulfateR01HL098950 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2010 to 2013
$1.6M
Software for automated interpretation of heparan sulfate tandem mass spectraR21HL131554 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2015 to 2016
$761k
NHLBI NIH HHS R01HL098950NHLBI NIH HHS R21 HL131554NIGMS NIH HHS P41 GM103390NIGMS NIH HHS P41GM103390NIGMS NIH HHS P41 GM104603NIGMS NIH HHS P41GM104603
6 · The paper itself

Abstract

Heparan sulfate (HS) 3-O-sulfation determines the binding specificity of HS/heparin for antithrombin III and plays a key role in herpes simplex virus (HSV) infection. However, the low natural abundance of HS 3-O-sulfation poses a serious challenge for functional studies other than the two cases mentioned above. By contrast, multiple distinct isoforms of 3-O-sulfotranserases exist in mammals (up to seven isoenzymes). Here we describe a novel peeling reaction that specifically degrades HS chains with 3-O-sulfated glucosamine at the reducing-end. When HS/heparin is enzymatically depolymerized for compositional analysis, 3-O-sulfated glucosamine at the reducing ends appears to be susceptible to degradation under mildly basic conditions. We propose a 3-O-desulfation initiated peeling reaction mechanism based on the intermediate and side-reaction products observed. Our discovery calls for the re-evaluation of the natural abundance and functions of HS 3-O-sulfation by taking into consideration the negative impact of this novel peeling reaction.

Indexed as

Chromatography, LiquidGlucosamineHeparan SulfateHeparinHumansMass SpectrometryOligosaccharidesProtein BindingSulfatesSulfotransferasesGlucosamineglucosamine 3-O-sulfateHeparan SulfateHeparinOligosaccharidesSulfatesSulfotransferases

Identifiers

PMID25486437
PMCPMC4287833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.